Page 14 - Read Online
P. 14

Page 4 of 8                                                             Qin et al. Vessel Plus 2020;4:2  I  http://dx.doi.org/10.20517/2574-1209.2019.22

               Table 1. Demographic, clinical, and angiographic characteristics of the subjects
               Variables                                Pro-UK group (n = 127)  Control group (n = 185)  P-value
               Age (years)                                59.56 ± 12.58           61.34 ± 11.73    0.203
               Male [n (%)]                               109 (85.83%)            146 (78.92%)     0.121
               Hypertension [n (%)]                       70 (55.12%)             113 (61.08%)     0.293
               Hyperlipemia [n (%)]                       34 (26.77%)             69 (37.30%)      0.052
               Diabetes [n (%)]                           25 (19.69%)             39 (21.08%)      0.764
               Smoking [n (%)]                            51 (40.16%)             65 (35.14%)      0.367
               Killip [n (%)]                                                                      0.259
                  I                                       101 (79.53%)            149 (80.54%)
                  II                                      10 (7.87%)              23 (12.43%)
                  III                                     12 (9.45%)              10 (5.41%)
                  IV                                      4 (3.15%)               3 (1.62%)
               pre-PCI TIMI classification [n (%)]                                                 < 0.001
                  0                                       107 (84.25%)            121 (65.41%)
                  1                                       14 (11.02%)             35 (18.92%)
                  2                                       6 (4.72%)               29 (15.68%)
               Time from symptom onset to balloon dilatation (h)  6.00 (4.50-9.00)  7.00 (5.00-10.00)  0.193
               Time from admission to balloon dilatation (min)  65.00 (48.50-85.00)  64.00 (47.00-93.00)  0.202
               Infarction-related artery [n (%)]                                                   0.083
                  LM                                      2 (1.57%)               4 (2.16%)
                  LAD                                     56 (44.09%)             93 (50.27%)
                  LCX                                     8 (6.30%)               23 (12.43%)
                  RCA                                     61 (48.03%)             65 (35.14%)
               Number of implanted stents [n (%)]                                                  0.864
                  PTCA                                    7 (5.51%)               8 (4.32%)
                  1 stent                                 91 (71.65%)             134 (72.43%)
                  2 stent                                 26 (20.47%)             36 (19.46%)
                  3 stents                                3 (2.36%)               7 (3.78%)
               Suction catheter [n (%)]                   15 (11.81%)             7 (3.78%)        0.007
               IABP used [n (%)]                          6 (4.72%)               11 (5.95%)       0.640
               Temporary pacemaker [n (%)]                23 (18.11%)             27 (14.59%)      0.406
               LM: left main stem; LCX: left circumflex artery; RCA: right coronary artery; IABP: intra-aortic balloon pump; PTCA: percutaneous
               transluminal coronary angioplasty; PCI: percutaneous coronary intervention; TIMI: thrombolysis in myocardial infarction; Pro-UK:
               prourokinase; LAD: left anterior descending branch

               Evaluation of clinical effectiveness
               The following indexes of the two groups were analyzed: the TIMI classification of the IRA immediately
               after surgery and the corrected TIMI frame count (CTFC) were used to assess the blood perfusion of
               culprit vessels; whether the ST segment had decreased by more than 50% at 90 min; and whether the peak
               of CK-MB and cTnI had decreased by more than 50%. There were no significant differences in the indexes
               of color Doppler echocardiography (LVEF, LVEDd, ventricular aneurysm, and ventricular thrombus)
               within seven days after surgery (P > 0.05), but there was a significant difference in the TIMI classification,
               CTFC, and CK peak value (P < 0.05) between the two groups [Table 2].

               Clinical safety assessment
               Eight patients had gastrointestinal bleeding. Two patients experienced cerebral hemorrhage in the Pro-
               UK group, while 12 patients experienced gastrointestinal bleeding in the control group. There was no
               significant difference in the severity of complications (P > 0.05) or the length of hospital stay (P > 0.05)
               [Table 3] between the two groups. There was no significant difference in the VT/VF between the two
               groups (P > 0.05), but there was a significant difference in the third-degree atrioventricular block (III° AVB)
               (P < 0.05) between the two groups [Table 3].

               Follow-up results
               Cardiovascular Major Adverse Events (MACEs) is a clinically viable technique for accurate, rapid, and
               safe evaluation of myocardial perfusion. In this study, MACE events included stent thrombosis, angina
   9   10   11   12   13   14   15   16   17   18   19